Approval · Notice of Compliance 4046 · 1997
RESPIGAM: Notice of Compliance 4046
Issued August 20, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 4046
- Date
- August 20, 1997
- Company
- Medimmune Inc.Gaithersburg, Maryland, United States
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Priority-NAS
- Therapeutic class
- Passive immunizing agent